Skip to content

Understanding of Genetic Risk Information for Type 2 Diabetes

Implications of Health and Genetic Literacy for Genomic Medicine

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01186354
Enrollment
300
Registered
2010-08-23
Start date
2010-07-31
Completion date
2012-01-31
Last updated
2012-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

Type 2 diabetes, health literacy, genetic literacy, genetic risk

Brief summary

This research study is being conducted to learn about how health and genetic literacy (i.e., how well a person understands health and genetic information) affects a person's ability to understand genetic risk information for Type 2 diabetes and whether that person chooses to change their lifestyle and health behaviors to reduce their risk. The investigators also want to learn if the manner in which the genetic risk information is communicated affects the level of understanding and potential behavior changes. Participants will be tested for genetic risk of developing Type 2 diabetes and will received results either via a web-based computer program, or in-person from a genetic counselor.

Interventions

BEHAVIORALReceiving results via genetic counselor

participants will receive genetic risk information for Type 2 diabetes from a board certified genetic counselor

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Ages 18 or older * Speak fluent English * Have an email address and access to the internet * Not diagnosed with type 2 diabetes

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Accurate understanding of genetic risk informationassessed at follow-up 1 week, 3 months and 6 months after receiving results

Secondary

MeasureTime frame
Impact on behavior changeassessed upon follow-up (3 mon, 6 mon)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026